Bone & Joint 360 Vol. 3, No. 3 Roundup360

Shoulder & Elbow


Shoulder

Reverse shoulder arthroplasty OK in trauma

The treatment of displaced four-part proximal humeral fractures is not getting any easier. With the recent reporting of the PROPHER study, describing no difference between operative stabilisation and conservative management along with numerous other RCTs failing to show any real term differences between two interventions, it is difficult to know if patients have been doing universally well or universally badly with traditional treatments. One area where fixation, conservative treatment and conventional arthroplasty are unlikely to yield good results is in the displaced four-part proximal humeral fracture in the elderly where a combination of cuff arthropathy and the technical challenge of the surgery makes many outcomes poor.

An emerging option that offers the tantalising prospect of re-functioning the rotator cuff (which in many cases may be the cause of poor outcomes) while treating the proximal humeral fracture, may offer the answer to this complex problem. The difficulty of course is that like many tantalising options in trauma and orthopaedic surgery, the evidence base does not match the enthusiasm with which surgeons are embracing the new technology. Although randomised trials are ongoing, they will not report for a number of years and, as such, case series can be helpful in judging safety and providing some evidence base for treatment.

Researchers in Chicago (USA) have established a prospective case series of patients, all treated with a reverse total shoulder arthroplasty for three- and four-part proximal humeral fractures.4 The research team then age- and sex-matched these to a control group undergoing hemiarthroplasty and ORIF procedures. Outcomes were assessed with clinical outcome scores (American Shoulder and Elbow Surgeons (ASES), Short-Form 12-item (SF-12), and Simple Shoulder Test (SST)), range of movement and treatment cost evaluation.

Sadly, despite an excellent methodology, this is really a rather small study consisting of just nine patients in each group (27 in total) with a minimum follow-up of a year. Unsurprisingly, given the small numbers of patients, there were no real significant differences between any outcome scores although there was a significant improvement in range of movement in the frontal plane in the reverse TSA group.

Quite clearly, better and more robust data are required here. Although we applaud the authors for providing some data, there really isn’t enough here to draw any more meaningful a conclusion than that reverse arthroplasty may be used in the treatment of proximal humeral fractures. We await with baited breath a more robust (and larger!) study.

Resurfacing of the shoulder: a Danish perspective

Shoulder resurfacing is a bit of an enthusiast’s operation. Those won over by the arguments of Copeland and colleagues consider resurfacing an excellent option for almost any shoulder indication, with ease of revision and comparable functional results cited as reason enough for choosing shoulder resurfacing when indicated.

Like many ‘enthusiast’ operations, the majority of the scientific literature emerges from just a few centres, and so we were delighted to see an independent paper from Harlev (Denmark) which not only reported the longer-term results of shoulder resurfacing arthroplasty (SRA) but also the clinical outcomes.8 The study team identified a population of 772 patients (837 SRA), all of whom had their details entered onto the Danish Arthroplasty Register over a four-year period.

Clinical outcomes were reported at 12 months using the Western Ontario Osteoarthritis of the Shoulder (WOOS) index. Revision rates and patient survival were established using the national statistics office and revision data. Within the observation period of the study, just 7.5% (n = 63) required revision, with a cumulative five-year survival of just over 90%. Younger patients performed particularly badly in terms of clinical outcomes (mean 14.2 WOOS points poorer) but had no increased risk of revision. There appeared to be no differences between outcomes by model of arthroplasty.

This paper supports a middle view, that SRA are moderately successful, managing outcomes of 90% survival at five years. The preservation of bone stock and relatively low revision rate makes this a potentially attractive option for many patients.


Link to article